6
IASLC ATLAS OF ALK TESTING IN LUNG CANCER
List of Contributors
Editors
Ming Sound Tsao, MD, FRCPC
Pathologist and Senior Scientist, Princess Margaret Cancer Centre, University Health Network Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto Toronto, Canada
Fred R. Hirsch, MD, PhD
Professor, Department of Medicine Department of Pathology University of Colorado at Denver Denver, Colorado, USA
Yasushi Yatabe, MD, PhD
Chief, Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Nagoya, Japan
Contributing Authors
Elisabeth Brambilla, MD, PhD
Professor, Département d’Anatomie et Cytologie Pathologiques INSERM U823 Institut Albert Bonniot Centre Hospitalier Universitaire de Grenoble, Université Joseph Fourier Grenoble, France
Keith M. Kerr, FRCPath
Professor, Department of Pathology Aberdeen University Medical School Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom
Erik Thunnissen, MD, PhD
Consultant Pathologist, VU University Medical Center Amsterdam, The Netherlands
Sylvie Lantuéjoul, MD, PhD
Professor and Chair, Département d’Anatomie et Cytologie Pathologiques INSERM U 823 Institut Albert Bonniot Centre Hospitalier Universitair A Michallon, Université Joseph Fourier Grenoble, France
Marileila Varella-Garcia, PhD
Professor, Department of Medicine/ Medical Oncology Department of Pathology University of Colorado at Denver Denver, Colorado, USA
Lukas Bubendorf, MD
Professor and Head, Division of Cytopathology Institute for Pathology, University Hospital Basel Basel, Switzerland
Ignacio Wistuba, MD
Professor and Chair, Jay and Lori Eisenberg Endowed Professor Department of Translational Molecular Pathology The University of Texas MD Anderson Cancer Center Houston, Texas, USA
Jin-Haeng Chung, MD, PhD
Professor, Department of Pathology Seoul National University Bundang Hospital Seoul, South Korea
Kengo Takeuchi, MD, PhD
Pathology Project for Molecular Targets of the Cancer Institute Division of Pathology of the Cancer Institute Hospital Japanese Foundation for Cancer Research Tokyo, Japan
Akihiko Yoshida, MD, PhD
Attending Pathologist, Department of Pathology National Cancer Center Hospital Tokyo, Japan
IASLC ALK Testing Workshop attendees, Sorrento, Italy, 2013. Front row, left to right– Y. Yatabe, M. Varella-Garcia, E. Brambilla, S. Lantéujoul, R. Gaspo (Pfizer Oncology), J-H Chung; back row, left to right–A. Yoshida, I. Wistuba, F. R. Hirsch, M. S. Tsao, E. Thunnissen, L. Bubendorf, K. Kerr.